development partnership in Tirzepatide
BRIEF-Hungary's Richter and Adalvo expand co-development partnership in Tirzepatide Aug 6 (Reuters) - Hungary's Richter Gedeon Vegyeszeti Gyar Nyrt GDRB.BU says in a statement:
RICHTER AND ADALVO EXPAND GLOBAL CO-DEVELOPMENT PARTNERSHIP IN TIRZEPATIDE ACROSS DIABETES AND OBESITY CARE
THE COLLABORATION BUILDS ON THE COMPANIES' EARLIER PARTNERSHIP AROUND WEGOVY (SEMAGLUTIDE)
THE PARTNERSHIP IS ANCHORED BY SHARED INVESTMENT, A RESILIENT DUAL SUPPLY CHAIN AND A DELIBERATE FOCUS ON COST LEADERSHIP
Source text: [https://www.bse.hu/newkibdata/129512739/Tirzepatide_Aug2026_EN.pdf]
Further company coverage: GDRB.BU
(Reporting by Anita Komuves)
((KOMUVES.Anita@thomsonreuters.com;))
Recent news on Gedeon Richter
See all newsBrief: Hungary's Richter says US FDA accepted for review its new drug application for Fylrevy
Brief: Hungary's Richter Upgrades 2026 Pharma Clean EBIT Guidance To Double-Digit Growth
development partnership in Tirzepatide
AI in Hungary could unlock productivity gains of €15 billion, McKinsey says
Brief: Hungary's Richter and Hetero announce cooperation for development of semaglutide injection